SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Luca Antonioli, Corrado Blandizzi, Balázs Csóka, Pál Pacher, György Haskó, Adenosine signalling in diabetes mellitus—pathophysiology and therapeutic considerations, Nature Reviews Endocrinology, 2015,

    CrossRef

  2. 2
    Albert J Czaja, Adoptive cell transfer in autoimmune hepatitis, Expert Review of Gastroenterology & Hepatology, 2015, 1

    CrossRef

  3. 3
    Farhad Sahebjam, John M. Vierling, Autoimmune hepatitis, Frontiers of Medicine, 2015,

    CrossRef

  4. 4
    Osamu Yoshida, Lei Dou, Shoko Kimura, Shinichiro Yokota, Kumiko Isse, Simon C. Robson, David A. Geller, Angus W. Thomson, CD39 deficiency in murine liver allografts promotes inflammatory injury and immune-mediated rejection, Transplant Immunology, 2015, 32, 2, 76

    CrossRef

  5. 5
    Huihuang Huang, Ruonan Xu, Fang Lin, Chunmei Bao, Siyu Wang, Chengcheng Ji, Ke Li, Lei Jin, Jingsong Mu, Yonggang Wang, Lei Li, Lijian Sun, Biao Xu, Zheng Zhang, Fu-Sheng Wang, High circulating CD39+ regulatory T cells predict poor survival for sepsis patients, International Journal of Infectious Diseases, 2015, 30, 57

    CrossRef

  6. 6
    Marcial Sebode, Moritz Peiseler, Christina Weiler-Normann, Christoph Schramm, Ansgar W. Lohse, Johannes Herkel, Phenotypic alterations of regulatory T cells in autoimmune hepatitis: Causal or associated with treatment and remission?, Hepatology, 2015, 61, 2
  7. 7
    Charlotte R. Grant, Rodrigo Liberal, Giorgina Mieli-Vergani, Diego Vergani, Maria Serena Longhi, Regulatory T-cells in autoimmune diseases: Challenges, controversies and—yet—unanswered questions, Autoimmunity Reviews, 2015, 14, 2, 105

    CrossRef

  8. 8
    Charlotte R. Grant, Rodrigo Liberal, Yun Ma, Simon C. Robson, Giorgina Mieli-Vergani, Diego Vergani, Maria Serena Longhi, Reply, Hepatology, 2015, 61, 2
  9. 9
    Aldo J. Montano-Loza, Albert J. Czaja, Cell Mediators of Autoimmune Hepatitis and Their Therapeutic Implications, Digestive Diseases and Sciences, 2014,

    CrossRef

  10. 10
    Benjamin H Kaffenberger, Grace L Lee, Kelly Tyler, Derek V Chan, Wael Jarjour, Maria E Ariza, Marshall V Williams, Henry K Wong, Current and potential immune therapies and vaccines in the management of psoriasis, Human Vaccines & Immunotherapeutics, 2014, 10, 4, 876

    CrossRef

  11. 11
    Gideon M. Hirschfield, Tom Hemming Karlsen, Genetic Risks Link Autoimmune Hepatitis to Other Autoimmune Liver Disease, Gastroenterology, 2014, 147, 2, 270

    CrossRef

  12. 12
    Javier Ochoa-Repáraz, Lloyd H. Kasper, Gut microbiome and the risk factors in central nervous system autoimmunity, FEBS Letters, 2014, 588, 22, 4214

    CrossRef

  13. 13
    Muhammed Yüksel, Debby Laukens, Femke Heindryckx, Hans Van Vlierberghe, Anja Geerts, F. Susan Wong, Li Wen, Isabelle Colle, Hepatitis mouse models: from acute-to-chronic autoimmune hepatitis, International Journal of Experimental Pathology, 2014, 95, 5
  14. 14
    Richard Taubert, Matthias Hardtke-Wolenski, Fatih Noyan, Artur Wilms, Anna K. Baumann, Jerome Schlue, Sven Olek, Christine S. Falk, Michael P. Manns, Elmar Jaeckel, Intrahepatic regulatory T cells in autoimmune hepatitis are associated with treatment response and depleted with current therapies, Journal of Hepatology, 2014, 61, 5, 1106

    CrossRef

  15. 15
    Yunjie Lu, Jirong Wang, Jian Gu, Hao Lu, Xiangcheng Li, Xiaofeng Qian, Xiaoshan Liu, Xuehao Wang, Feng Zhang, Ling Lu, Rapamycin Regulates iTreg Function through CD39 and Runx1 Pathways, Journal of Immunology Research, 2014, 2014, 1

    CrossRef

  16. 16
    A. J. Czaja, Review article: chemokines as orchestrators of autoimmune hepatitis and potential therapeutic targets, Alimentary Pharmacology & Therapeutics, 2014, 40, 3